HealthMap

Corticosteroid-Induced Myopathy and Leg Weakness

Overview

• Prednisone and other corticosteroid medications are well known to potentially cause skeletal muscle weakness and atrophy (wasting).
• This condition is medically referred to as corticosteroid-induced myopathy or steroid myopathy.

Key Mechanisms

• Protein Breakdown: Corticosteroids promote protein catabolism (breakdown) and inhibit protein synthesis in muscle tissue.
• Selective Fiber Impact: They frequently affect Type II (fast-twitch) muscle fibers, which are crucial for rapid movements and strength.
• Lower Extremity Predilection: Weakness and atrophy often manifest preferentially in the proximal muscles of the lower extremities (hips, thighs) and sometimes the shoulders, making it difficult to stand up from a chair, climb stairs, or walk.

Contributing Factors

• Dosage and Duration: The risk and severity of muscle weakness generally increase with higher doses and prolonged use of prednisone.
• Individual Susceptibility: Nutritional status, underlying inflammatory conditions, and co-existing electrolyte imbalances (such as potassium depletion) can influence vulnerability.
• Physical Inactivity: Reduced mobility while on treatment can further accelerate muscle wasting.

Important Considerations

• Do not stop or alter prednisone intake abruptly, as sudden discontinuation can be dangerous; any adjustments must be managed by a qualified healthcare professional.
• Nutritional support, addressing potential deficiencies, and tailored physical activity or rehabilitation are often evaluated to help manage or mitigate muscle symptoms.